• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

HAWK study: Higher order OCT analysis for inflammatory signal biomarkers

Video

Justis P. Ehlers, MD, speaks on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.

Justis P. Ehlers, MD, The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research, Cole Eye Institute, Cleveland, Ohio, speaks with Ophthalmology Times®' Sheryl Stevenson on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.

Are there predictive factors that clinicians can identify in patients who may be more at risk for developing inflammation so that they can mitigate risk?

Learn what this research may mean for clinicians and their patients.

See more ASRS coverage here

Related Videos
© 2024 MJH Life Sciences

All rights reserved.